SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-09-007969
Filing Date
2009-02-10
Accepted
2009-02-10 16:06:03
Documents
4
Period of Report
2009-02-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a09-4959_28k.htm 8-K 38556
2 EX-10.1 a09-4959_2ex10d1.htm EX-10.1 137965
3 EX-10.2 a09-4959_2ex10d2.htm EX-10.2 50012
4 EX-10.3 a09-4959_2ex10d3.htm EX-10.3 116101
  Complete submission text file 0001104659-09-007969.txt   344209
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19319 | Film No.: 09585798
SIC: 2834 Pharmaceutical Preparations